Please fill out the Clinical Trial Inquiry form at the below link for more information.
The immune system is a collection of diverse cells, each with a distinct role in protecting us from infections and diseases. Among these are the natural killer (NK) cells, the body’s first line of defense. As part of the ‘innate’ immune response, NK cells have the ability to recognize and destroy abnormal (such as cancerous or virally-infected) cells and are uniquely powerful. They are always activated and ready to eliminate diseased cells without delay. We harness this power with our activated natural killer (aNK) platform based upon NK cells from a distinct cell line.
To further leverage the power of innate immune responses, we have developed a proprietary IL-15 superagonist, Anktiva® (N-803), which selectively activates NK cells and T effector cells, without activating regulatory T cells that may dampen responses. These platforms can be combined for clinical synergy in patients and such combination has produced complete responses in difficult-to-treat cancers, such as Merkel Cell Carcinoma (MCC), advanced pancreatic cancer, and advanced triple negative breast cancer (TNBC).
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.
State-of-the-art diagnosis and
treatment options for cancer patients
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.
Please complete the form on this page to connect with a CSSIFM research site and start your clinical trial journey
After you submit your info, a CSSIFM staff member will review your info. They will contact you to discuss available clinical trials and/or treatment options.
Depending on the trial, health insurance may be required.
Remember, there is never an obligation to join — we're here to help you make the best decision.
State-of-the-art diagnosis and treatment options for cancer patients
2040 East Mariposa Avenue
El Segundo, California 90245
Phone: 213-266-5600
Fax: 562-548-2304
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.
Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.